Compassion, Social Support, Flexibility, and Resilience Program for Women Surviving Breast Cancer
Launched by MEDIPOL UNIVERSITY · May 13, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Intervention studies aiming to increase psychological resilience in women with breast cancer after mastectomy are gaining increasing attention in the literature. Various studies highlight the positive effects of social support and psychological flexibility on the mental health of cancer patients. In particular, social support enhances the stress-coping capacity of cancer patients and strengthens their psychological resilience (Hulbert-Williams et al., 2015).
Acceptance and Commitment Therapy (ACT)-based interventions are considered an effective approach for coping with chronic illnesses. S...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female participants aged between 18 and 65 years.
- • Participants who have undergone a mastectomy.
- • Participants who voluntarily agree to participate in the study.
- Exclusion Criteria:
- • -
About Medipol University
Medipol University is a leading academic institution dedicated to advancing medical research and clinical innovation. With a strong emphasis on interdisciplinary collaboration, the university conducts rigorous clinical trials aimed at improving patient outcomes and enhancing healthcare practices. Leveraging state-of-the-art facilities and a team of experienced researchers and healthcare professionals, Medipol University is committed to contributing to the global medical community through ethical research and the development of novel therapeutic strategies. The institution fosters an environment of academic excellence and integrity, ensuring that all trials adhere to the highest standards of safety and efficacy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Trial Officials
Ela Arı, Assistant Professor
Principal Investigator
Medipol University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported